Text Size

Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Metabolic Technologies Inc.
ClinicalTrials.gov Identifier:
NCT01643265
First received: July 16, 2012
Last updated: February 13, 2013
Last verified: February 2013
History of Changes
  Purpose

The purpose of this study will allow us to examine how quickly and to what extent plasma amino acids levels rise after ingesting a single dose of either whey or albumin protein. The investigators anticipate that the amino acids from albumin concentrate protein will rise as quickly and to the same extent as amino acids from whey protein. These findings will help us to understand the biological availability of these proteins and efficacy of the supplement so that consumers may be presented with nutritional options.


Condition Intervention
Healthy Men and Women
 Dietary Supplement: Whey Milk Protein
Dietary Supplement: Bovine Albumin Concentrate

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Metabolic Technologies Inc.:

Primary Outcome Measures:
  • Amino acid concentration [ Time Frame: 210 minutes ] [ Designated as safety issue: No ]

Enrollment: 8
Study Start Date: July 2012
Study Completion Date: September 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Whey Milk Protein Dietary Supplement: Whey Milk Protein
20 grams of Whey Milk Protein
Experimental: Bovine Albumin Concentrate Dietary Supplement: Bovine Albumin Concentrate
20 grams of Bovine Albumin Concentrate

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • normal Healthy volunteers
  • free of serious illness/disease such as hypertension, kidney or liver disease

Exclusion Criteria:

  • taking dietary protein or amino acid supplements
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01643265

Locations
United States, Iowa
Iowa State University
Ames, Iowa, United States, 50011
Sponsors and Collaborators
Metabolic Technologies Inc.
Investigators
Principal Investigator: Rick Sharp, PhD Iowa State University
  More Information

No publications provided

Responsible Party: Metabolic Technologies Inc.
ClinicalTrials.gov Identifier: NCT01643265     History of Changes
Other Study ID Numbers: MTI2012-CS02
Study First Received: July 16, 2012
Last Updated: February 13, 2013
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 16, 2013